Vast Therapeutics is a clinical stage, airway immunology company that is dedicated to combating the increasing global threat of antibiotic-resistant pathogens. By leveraging their proprietary nitric oxide technology, Vast Therapeutics aims to preserve lung function and break the vicious cycle of infection and chronic inflammation in respiratory diseases. Their innovative portfolio includes a range of small and large molecule new chemical entities that provide broad-spectrum antimicrobial activity without the risk of developing drug resistance.

This ensures that their products are effective in addressing various respiratory conditions such as bronchiectasis, NTM lung disease, and cystic fibrosis. Located at 615 Davis Drive, Suite 800 in Morrisville, NC, Vast Therapeutics is at the forefront of the biopharmaceutical industry and biotechnology sector. They are committed to advancing their research and development efforts to develop cutting-edge solutions for respiratory ailments.

Stay updated on their latest advancements by signing up for email alerts on their website. Together, we can overcome the challenges posed by antibiotic-resistant pathogens with Vast Therapeutics